532 related articles for article (PubMed ID: 25873648)
1. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
2. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
[TBL] [Abstract][Full Text] [Related]
3. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
[TBL] [Abstract][Full Text] [Related]
4. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
5. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
[TBL] [Abstract][Full Text] [Related]
6. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
Yousef YA; Al-Hussaini M; Mehyar M; Sultan I; Jaradat I; AlRawashdeh K; Khurma S; Deebajah R; Nawaiseh I
Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
[TBL] [Abstract][Full Text] [Related]
7. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
[TBL] [Abstract][Full Text] [Related]
8. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
9. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
10. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
[TBL] [Abstract][Full Text] [Related]
11. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of high risk histopathology in retinoblastoma.
Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
[TBL] [Abstract][Full Text] [Related]
13. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma.
Mohammad M; Shehada R; Al-Nawaiseh I; Mehyar M; AlHussaini M; Jaradat I; Sultan I; Halalsheh H; Khzouz J; Yousef YA
Eur J Ophthalmol; 2023 Sep; 33(5):2014-2023. PubMed ID: 36760120
[TBL] [Abstract][Full Text] [Related]
14. High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study.
Alkatan HM; Al-Dahmash SA; Almesfer SA; AlQahtani FS; Maktabi AMY
Int Ophthalmol; 2020 Nov; 40(11):2875-2887. PubMed ID: 32632618
[TBL] [Abstract][Full Text] [Related]
15. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
16. Vitrectomy in eyes with unsuspected retinoblastoma.
Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
[TBL] [Abstract][Full Text] [Related]
17. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
[TBL] [Abstract][Full Text] [Related]
18. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
